SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 18, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $206K total
Actionable Insight • Neutral

The sales are small relative to market cap and accompanied by derivative exercises, suggesting routine portfolio management rather than a negative signal. Monitor the next 10-Q for any fundamental deterioration, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
ARQT ▲ +22.84% at T+20d
NEUTRAL call +22.84% · α vs SPY +23.75% · entry $25.96 → $31.89
Next anchor: T+60d in 7w
Latest observation: T+24 +21.66% FF3 residual α
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
+7.01%
call +7.01% · α +7.03%
$27.78
settled 5w ago
T+5d
+5.28%
call +5.28% · α +6.30%
$27.33
settled 4w ago
T+20d
+22.84%
call +22.84% · α +23.75%
$31.89
settled 10d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Two insiders at Arcutis Biotherapeutics sold a combined $206K in open-market sales over a one-week window. Director Howard G. Welgus sold $114K alongside derivative exercises, and officer Masaru Matsuda sold $92K. The total is ~0.06% of the company's $326M market cap — well below the 0.1% materiality threshold — making this a routine, non-informative cluster.

Key Financial Metrics

Direction
selling
Total Value
$206.0K
Insiders
2

Key Facts

  • Total insider sales: $206K (0.06% of market cap)
  • Director Howard G. Welgus sold $114K in open-market sales on 2026-09-15
  • Officer Masaru Matsuda sold $92K in open-market sales on 2026-09-16
  • Welgus also exercised multiple derivative tranches (non-cash and cash) on the same day as his sales
  • No insider open-market purchases were reported in the cluster

Financial Impact

Total insider sales of $206K represent approximately 0.06% of the company's $326M market cap — a trivial amount with no material financial impact.

insider ownershipdilution

Risk Factors

  • Insider sales, while small, could precede broader selling if fundamentals weaken
  • Derivative exercises increase share count, creating modest dilution pressure

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1789764732325
22 reports for ARQT
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +14.74%Mar 2, 2026
Filters
Rows
Reports for ARQT — sortable, filterable
TypeNow
Oct 21, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$32.20awaiting T+20—$31.79 (−1.27%)
Oct 5, 2026
21d ago
SC 13G/A
NEUTRAL ★ 3/10
$25.15awaiting T+20—$31.79 (+26.40%)
Sep 29, 2026
27d ago
Press Release
NEUTRAL ★ 3/10
$26.75awaiting T+20—$31.79 (+18.84%)
Sep 18, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.96 $31.89▲ +22.84%▲ +23.75%$31.79 (+22.46%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.38 $28.82▲ +13.55%▲ +13.35%$31.79 (+25.26%)
Aug 24, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.86 $26.38▲ +6.11%▲ +5.87%$31.79 (+27.88%)
Aug 21, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.78 $27.78▲ +12.11%▲ +10.81%$31.79 (+28.29%)
Aug 19, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.35 $25.38▲ +0.12%▲ +0.12%$31.79 (+25.40%)
Aug 11, 2026
10w ago
144
NEUTRAL ★ 3/10
$26.28 $23.38▼ −11.04%▼ −9.14%$31.79 (+20.97%)
Aug 5, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.43 $23.66▼ −10.48%▼ −11.08%$31.79 (+20.28%)
Showing 10 of 22

US Market Status

Market Open — Closes in 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026